ImmunoGen Competitors and Similar CompaniesClear all
Immunomedics's competitors and similar companies include Ablynx.
 Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. |  Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | |
Founding Date | Founding Date 1982 | Founding Date 2001 |
Type | Type Subsidiary | Type Subsidiary |
Tags | ||
Locations | Locations Morris Plains, US HQ | Locations Gent, BE HQ |
Employees | Employees 8914% decrease | Employees 1252% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $295k (FY, 2019) | Revenue (est.) €85.2m (FY, 2016) |
Net income | Net income ($357.3m) (FY, 2019) | Net income (€1.1m) (FY, 2016) |
Operating ⚠ | ||
Patents (US) | Patents (US) 405 (Sep, 2022) | Patents (US) 50 (Q2, 2017) |
Funding | ||
Total funding raised | Total funding raised $ 30m | Total funding raised $ 498.8m |
For sources of this data, please see the company profile
View Company Profiles
Ablynx
HQ
Gent, BE
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
View company